FDA OKs Another Monoclonal Antibody to Protect Against RSV in Infants

(MedPage Today) — The FDA approved clesrovimab (Enflonsia) to prevent lower respiratory tract disease from respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, drugmaker Merck announced on Monday.
The long…